707. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 539 of 19 February, whether any external organisations, advocacy groups, academic institutions, clinical bodies, or international organisations were consulted in relation to the inclusion of WPATH Standards of Care Version 7 within the Consultant Applications Advisory Committee submission referenced. [41276/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn under the heading Healthcare Policy.
247 questions match, newest first.
709. Deputy Ken O'Flynn asked the Minister for Health whether any review has been undertaken by the HSE or their Department concerning the evidential basis previously relied upon in relation to WPATH Standards of Care Version 7 following recent international reviews and developments in gender healthcare governance. [41278/26]
710. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 539 of 19 February, whether the updated Gender Healthcare Model of Care currently under development by the HSE will continue to reference or rely upon WPATH Standards of Care; and if not, the reasons for any proposed departure from the approach referenced. [41279/26]
713. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 539 of 19 February, whether any revised consultant job description, revised governance structure, or revised evidential framework is currently being developed as part of the updated Gender Healthcare Model of Care referenced in the reply. [41282/26]
714. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 539 of 19 February, whether any formal audit, review, or retrospective governance assessment has been undertaken concerning the development and approval process associated with the National Gender Service Model of Care 2018 and the associated consultant psychiatry post referenced. [41283/26]
716. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 539 of 19 February, whether any international evidence reviews, systematic reviews, or external policy analyses are currently being relied upon in updating the Gender Healthcare Model of Care referenced; and whether these will be published upon completion. [41285/26]
717. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 539 of 19 February, whether any Departmental oversight or reporting arrangements existed between the HSE and the Department of Health regarding implementation of the National Gender Service Model of Care 2018 and the consultant child and adolescent psychiatry post referenced. [41286/26]
718. Deputy Ken O'Flynn asked the Minister for Health whether any national clinical governance framework specific to gender healthcare for children and adolescents currently exists within the HSE pending completion of the revised Gender Healthcare Model of Care. [41287/26]
733. Deputy Ken O'Flynn asked the Minister for Health the current status of the HSE expert group report on the implications of the Cass Review for gender identity services for children and young people in Ireland; when this report will be published; and if she will make a statement on the matter. [41314/26]
734. Deputy Ken O'Flynn asked the Minister for Health the current status of the HSE’s updated Clinical Model of Care for Gender Healthcare; whether a draft has been completed; the expected timeline for publication and implementation; and if she will make a statement on the matter. [41315/26]
735. Deputy Ken O'Flynn asked the Minister for Health the composition and membership of the expert group convened by the HSE’s Chief Clinical Officer to examine the implications of the final Cass Review for gender identity services in Ireland; the terms of reference of that group; the number of times it has met; and if she will make a statement on the matter. [41316/26]
1319. Deputy Ken O'Flynn asked the Minister for Health whether the absence of a national waiting list or central referral pathway for PrEP has been formally identified within the HSE or Department of Health as a patient safety, governance or access risk. [39276/26]
1423. Deputy Ken O'Flynn asked the Minister for Health whether the Department intends to establish a national classification framework distinguishing medically necessary procedures from elective, quality-of-life, experimental or non-urgent procedures for public funding and governance purposes. [39782/26]
964. Deputy Ken O'Flynn asked the Minister for Health whether any internal HSE operational manual, assessment framework, decision-support document, checklist, or staff guidance exists for officials administering the Treatment Abroad Scheme beyond the EU Regulations themselves; and if so, if copies will be provided. [36560/26]
965. Deputy Ken O'Flynn asked the Minister for Health whether officials administering the treatment abroad scheme are required to follow any standardised evidential criteria when assessing whether treatment is unavailable within the State or unavailable within a clinically appropriate timeframe. [36561/26]
966. Deputy Ken O'Flynn asked the Minister for Health whether any audit, quality assurance, peer review, or consistency-review mechanism exists for treatment abroad scheme eligibility determinations; and if so, to provide details. [36562/26]
967. Deputy Ken O'Flynn asked the Minister for Health whether any appeals, reconsideration, or secondary review process exists for applicants refused approval under the treatment abroad scheme; and if so, to provide details of the process and annual refusal figures since 2020. [36563/26]
968. Deputy Ken O'Flynn asked the Minister for Health whether any category-specific governance arrangements apply to overseas referrals under the treatment abroad scheme involving gender-related healthcare interventions, including enhanced approval, audit, safeguarding, or specialist review requirements. [36564/26]
969. Deputy Ken O'Flynn asked the Minister for Health the number of officials or clinical advisers currently involved in assessing treatment abroad scheme applications and whether any formal training programme or accreditation process applies to those making eligibility determinations. [36565/26]
970. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any central database recording the clinical category, destination country, expenditure, approval rationale, and outcome of treatment abroad scheme referrals; and if not, whether the absence of such data has been identified as a governance risk. [36566/26]
971. Deputy Ken O'Flynn asked the Minister for Health whether any procedures funded under the treatment abroad scheme are classified internally by the HSE as elective, quality-of-life enhancing, cosmetic, experimental, or non-urgent; and if she will provide the classification framework used. [36567/26]
973. Deputy Ken O'Flynn asked the Minister for Health whether any independent value-for-money review has ever been conducted specifically on the treatment abroad scheme; if so, to provide the dates and findings; and if not, why not. [36569/26]
974. Deputy Ken O'Flynn asked the Minister for Health whether any national consistency review is carried out to assess whether similar clinical cases receive similar treatment abroad scheme approval outcomes across different hospitals or consultants. [36570/26]
975. Deputy Ken O'Flynn asked the Minister for Health whether the Department has assessed the governance implications of approving overseas procedures in the absence of a nationally agreed definition of "medical necessity". [36571/26]
976. Deputy Ken O'Flynn asked the Minister for Health whether her Department intends to establish a national classification framework distinguishing medically necessary procedures from elective or quality-of-life procedures for public funding purposes. [36572/26]